Differences between revisions 5 and 6
Revision 5 as of 2015-10-27 15:03:05
Size: 1783
Editor: aerdemir
Comment:
Revision 6 as of 2015-10-27 15:06:42
Size: 1925
Editor: aerdemir
Comment:
Deletions are marked like this. Additions are marked like this.
Line 36: Line 36:
  * Perform a literature search on stiffness properties of transverse ligament, capsule, and medial collateral ligament/menisci attachment..

Recurring Meeting of Cleveland Clinic Core Team

Date: October 27, 2015

Time: 10:30 AM EST

Means: In person meeting

Attendees:

  1. Ahmet Erdemir
  2. Craig Bennetts
  3. Snehal Chokhandre
  4. Robb Colbrunn
  5. Tara Bonner

Agenda:

  1. Discuss immediate action items from the last meeting.
  2. Discuss manuscripts' progress.
  3. Discuss tissue testing protocol evaluation progress.
  4. Decide immediate action items for the next meeting.
  5. Other.

Immediate Action Items:

  • Ahmet
    • Disseminate joint mechanics testing data for oks004.
    • Start reviewing and accumulating segmentation and geometry generation specifications.
  • Craig
    • Start evaluating previous segmentation approaches by the team as a path to segmentation of oks001.
    • Perform a literature search on stiffness properties of transverse ligament, capsule, and medial collateral ligament/menisci attachment..
  • Robb
    • Evaluate oks004 joint mechanics data to confirm processing of tdms files.
  • Snehal
    • Provide Craig access to Katie Stemmer's work.

Ongoing Action Items:

  • Ahmet
    • Prepare flowcharts to describe data flow for pre-processing of joint kinematics/kinetics data.
  • Craig
    • Anatomical imaging manuscript.
    • Large-scale analysis of simulation parameters for convergence.
  • Snehal
    • Pivot shift manuscript.
    • Cruciate ligament modeling & simulation.

  • Robb
    • Patellofemoral joint experimentation manuscript.
  • Tara
    • Tibiofemoral joint experimentation manuscript.

Notes:

  1. Discuss immediate action items from the last meeting.
    • TBD
  2. Discuss manuscripts' progress.
    • TBD
  3. Discuss tissue testing protocol evaluation progress.
    • TBD
  4. Decide immediate action items for the next meeting.
    • TBD
  5. Other.
    • TBD

RecurringMeetings/2015-10-27 (last edited 2016-05-04 22:09:48 by localhost)